CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324725
- Phone
- 833 275 2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 3/A Insider 3/A
- 3/A Insider 3/A
- 8-K Event Material agreement · Delisting notice · Bylaws or fiscal year change · Other events
- 4 Open-market buy Chief Strategy Officer bought 20,000 shares at $2.80 ($56,000)
- 4 Open-market buy Director bought 11,000 shares at $4.35 ($47,850)
- 3/A Insider 3/A
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.35 ($4,350)
- 4 Open-market buy Director bought 34,400 shares at $4.35 ($149,640)
- 424B4 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 12 of 14 · 276 filings